Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Productivity burden of hypertension in Japan

Abstract

In the present study, we aimed to estimate the impact of hypertension in the working-age Japanese population. We developed life table models to estimate total deaths, years of life lived, and productivity-adjusted life years lived (a newly developed metric for quantifying the burden of acute and chronic health conditions on work productivity) among Japanese individuals with hypertension aged 20–64 years, with simulated follow-up until age 65 years. Data inputs were drawn from local population statistics and published sources. Gross domestic product per person employed, a measure of labor productivity, was used to assign an economic value to each productivity-adjusted life year lived. Outcomes and costs were discounted by 2% annually. In 2017, 26.3 million Japanese individuals aged 20–64 years (37.5%) had hypertension. Of these people, 23.7% were treated and had controlled blood pressure, 23.2% were treated but had uncontrolled blood pressure, and 53.1% were untreated. During the simulated follow-up until age 65 years, 335,342 deaths (28.0% of total deaths), 1.6 million years of life (0.8% of total), 3.1 million productivity-adjusted life years (1.9% of total), and US$242.9 billion or 28.3 trillion Japanese yen of gross domestic product were lost to hypertension. Our findings highlight the considerable economic burden of hypertension in Japan, as well as the importance of effective strategies for hypertension prevention and management, which are likely to deliver a significant return on investment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–237. https://doi.org/10.1038/s41581-019-0244-2. 2020/04/01

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481. https://doi.org/10.1038/s41440-019-0284-9. 2019/09/01

    Article  PubMed  Google Scholar 

  3. World Health Organization. Hypertension. Internet. 2020. Updated 13 September 2019. Accessed 5 August, 2020. https://www.who.int/news-room/fact-sheets/detail/hypertension

  4. Japan, Ministry of Health, Labour and Welfare. The results of the National Health and Nutrition Survey 2017 (in Japanese). Internet. 2020. Accessed 17 August, 2020. https://www.mhlw.go.jp/stf/houdou/0000142359.html

  5. Sakamoto H, Rahman M, Nomura S, Okamoto E, Koike S, Yasunaga H, et al. Japan Health System Review. 8. 2018. https://apps.who.int/iris/bitstream/handle/10665/259941/9789290226260-eng.pdf;jsessionid=47F729C7DDD4A8AD7463CC8F0ABEE3FC?sequence=1

  6. Hisamatsu T, Segawa H, Kadota A, Ohkubo T, Arima H, Miura K. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines. Hypertens Res. 2020. https://doi.org/10.1038/s41440-020-0508-z

  7. Hirawa N, Umemura S, Ito S. Viewpoint on guidelines for treatment of hypertension in Japan. Circ Res. 2019;124:981–3. https://doi.org/10.1161/CIRCRESAHA.119.314991

    Article  CAS  PubMed  Google Scholar 

  8. The Japanese Society of Hypertension. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37:253. https://doi.org/10.1038/hr.2014.20. 2014/04/01

    Article  Google Scholar 

  9. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics − 2020 update: a report from the American Heart Association. Circulation. 2020;141:e139–e596. https://doi.org/10.1161/CIR.0000000000000757

    Article  PubMed  Google Scholar 

  10. Japan, Ministry of Health Labour and Welfare. Summary of the medical health expenditure in 2017 (in Japanese). 2017. https://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/17/index.html

  11. The Internal Revenue Service. Yearly average currency exchange rates. The United States government. 2020. Updated 10 January 2020. Accessed August 4, 2020. https://www.irs.gov/individuals/international-taxpayers/yearly-average-currency-exchange-rates

  12. Hird RT, Zomer E, Owen JA, Magliano JD, Liew D, Ademi Z. Productivity burden of hypertension in Australia: a life table modeling study. Hypertension. 2019;73:777–84. https://doi.org/10.1161/HYPERTENSIONAHA.118.12606

    Article  CAS  PubMed  Google Scholar 

  13. Ademi Z, Ackerman IN, Zomer E, Liew D. Productivity-Adjusted Life-Years: A New Metric for Quantifying Disease Burden. PharmacoEconomics. 2021;39:271–3.

    Article  Google Scholar 

  14. Magliano DJ, Martin VJ, Owen AJ, Zomer E, Liew D. The productivity burden of diabetes at a population level. (Report). Diabetes Care. 2018;41:979. https://doi.org/10.2337/dc17-2138

    Article  PubMed  Google Scholar 

  15. Hird TR, Zomer E, Owen A, Chen L, Ademi Z, Magliano DJ, et al. The impact of diabetes on productivity in China. Diabetologia. 2019;62:1195–203. https://doi.org/10.1007/s00125-019-4875-4. 2019/07/01

    Article  PubMed  Google Scholar 

  16. Owen AJ, Maulida SB, Zomer E, Liew D. Productivity burden of smoking in Australia: a life table modelling study. Tob Control. 2019;28:297. https://doi.org/10.1136/tobaccocontrol-2018-054263

    Article  PubMed  Google Scholar 

  17. Tan QY, Zomer E, Owen AJ, Chin KL, Liew D. Impact of tobacco use on health and work productivity in Malaysia. Tob Control. 2020;29:111. https://doi.org/10.1136/tobaccocontrol-2018-054677

    Article  PubMed  Google Scholar 

  18. Afroz A, Hird TR, Zomer E, Owen A, Chen L, Ademi Z, et al. The impact of diabetes on the productivity and economy of Bangladesh. BMJ Glob Health. 2020;5:e002420. https://doi.org/10.1136/bmjgh-2020-002420

    Article  PubMed  PubMed Central  Google Scholar 

  19. Foster E, Chen Z, Zomer E, Rychkova M, Carney P, O’Brien TJ, et al. The costs of epilepsy in Australia: A productivity-based analysis. Neurology. 2020;95:e3221–e31.

    Article  Google Scholar 

  20. Uli RE, Satyana RPU, Zomer E, Magliano D, Liew D, Ademi Z. Health and productivity burden of coronary heart disease in the working Indonesian population using life-table modelling. BMJ Open. 2020;10:e039221. https://doi.org/10.1136/bmjopen-2020-039221

    Article  PubMed  PubMed Central  Google Scholar 

  21. Center for Outcomes Research and Economic Evaluation for Health. Guideline for preparing cost-effectiveness evaluation to the central social insurance medical council internet. National Institute of Public Health. 2020. Accessed 8 August, 2020. https://c2h.niph.go.jp/tools/guideline/guideline_en.pdf

  22. Statistics Bureau of Japan. Table 2–5 Population by Age (2015 and 2017). Internet. Statistics Bureau, Ministry of Internal Affairs and Communications. 2020. Accessed 8 August, 2020. https://www.stat.go.jp/english/data/nenkan/68nenkan/index.html

  23. Statistics Bureau of Japan. Table 2−22 Life Table (2017). Internet. Statistics Bureau, Ministry of Internal Affairs and Communications, 2020. Accessed 8 August, 2020. https://www.stat.go.jp/english/data/nenkan/69nenkan/1431-02.html

  24. Statistics Bureau of Japan. Table 19–2 labour force by age group and labour force status (2005–2017). Internet. Statistics Bureau, Ministry of Internal Affairs and Communications, 2020. Accessed 8 August, 2020. https://www.stat.go.jp/english/data/nenkan/68nenkan/index.html

  25. Statistics Bureau of Japan. The National Health and Nutrition Survey 2017. Table 23–1 Blood pressure status (including treated hypertension) (in Japanese). Internet. National Statistics Center, 2020. Accessed 8 August, 2020. https://www.e-stat.go.jp/stat-search/files?page=1&layout=datalist&toukei=00450171&tstat=000001041744&cycle=7&tclass1=000001123258&cycle_facet=cycle

  26. Statistics Bureau of Japan. The National Health and Nutrition Survey 2017. Table 23–2 Blood pressure status (excluding treated hypertension) (in Japanese). Internet. National Statistics Center, 2020. Accessed 8 August, 2020. https://www.e-stat.go.jp/stat-search/files?page=1&layout=datalist&toukei=00450171&tstat=000001041744&cycle=7&tclass1=000001123258&cycle_facet=cycle

  27. Ikeda N, Takimoto H, Imai S, Miyachi M, Nishi N. Data resource profile: The Japan National Health and Nutrition Survey (NHNS). Int J Epidemiol. 2015;44:1842–9. https://doi.org/10.1093/ije/dyv152

    Article  PubMed  Google Scholar 

  28. National Institute of Heatlh and Nutrition. Health Japan 21 (the second term). Internet. National Institute of Heatlh and Nutrition, 2020. Accessed 17 August, 2020. https://www.nibiohn.go.jp/eiken/kenkounippon21/en/eiyouchousa/

  29. Zhou D, Xi B, Zhao M, Wang L, Veeranki SP. Uncontrolled hypertension increases risk of all- cause and cardiovascular disease mortality in US adults: the NHANES III linked mortality study. Sci Rep. 2018;8:9418 https://doi.org/10.1038/s41598-018-27377-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Unmuessig V, Fishman PA, Vrijhoef HJM, Elissen AMJ, Grossman DC. Association of controlled and uncontrolled hypertension with workplace productivity. J Clin Hypertension. 2016;18:217–22. https://doi.org/10.1111/jch.12648

    Article  Google Scholar 

  31. Japan, Ministry of Health Labour and Welfare. Summary of Comprehensive Survey of Working Conditions in 2018 (in Japanese), 2020. Accessed 8 August, 2020. https://www.mhlw.go.jp/toukei/itiran/roudou/jikan/syurou/18/dl/gaikyou.pdf

  32. Organisation for Economic Co-operation and Development. Measuring productivity - OECD Manual. Internet. OECD publishing, 2020. Accessed 14 August, 2020. https://www.oecd-ilibrary.org/industry-and-services/measuring-productivity-oecd-manual_9789264194519-en#:~:text=Productivity%20%2D%20OECD%20Manual-,Measurement%20of%20Aggregate%20and%20Industry%2Dlevel%20Productivity%20Growth,constructing%20industry%2Dlevel%20productivity%20indicators.

  33. World Bank. GDP per person employed (constant 2017 PPP $) - Japan. Internet. The World Bank Group. Accessed July 27, 2020. https://data.worldbank.org/indicator/SL.GDP.PCAP.EM.KD?locations=JP

  34. United Nations. Indicators for monitoring the Millenium Development Goals − 1.4 Growth rate of GDP per person employed. Internet. United Nations, 2020. Updated 20 October 2012. Accessed 13 August, 2020. http://mdgs.un.org/unsd/mi/wiki/1-4-Growth-rate-of-GDP-per-person-employed.ashx

  35. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013–20. World Health Organization; 2013.

  36. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States. Circulation. 2011;123:933–44. https://doi.org/10.1161/CIR.0b013e31820a55f5

    Article  PubMed  Google Scholar 

  37. Nakamura K, Kaihatsu S, Yagi T. Productivity improvement and economic growth: lessons from Japan. Economic Anal Policy. 2019;62:57–79. https://doi.org/10.1016/j.eap.2018.11.002

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

E. Asakura performed the analysis and interpretation of the data. E. Asakura, E. Zomer, Z. Ademi, and D. Liew jointly conceived the study and made a substantial contribution to the interpretation of data. E. Zomer and Z. Ademi made a substantial contribution to the analytical strategy. E. Asakura wrote the first draft of the article, and E. Zomer, Z. Ademi, and D. Liew reviewed and revised the article. All authors approved the final version of the article. E. Asakura and E. Zomer were the guarantors of this study and, as such, had full access to all the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis. The interpretation and conclusions contained in this study are those of the authors alone.

Funding information

No funding was received for this study.

Corresponding author

Correspondence to Zanfina Ademi.

Ethics declarations

Conflict of interest

E. Asakura and Z. Ademi report no conflicts of interest. D. Liew has received honoraria or study grants from AbbVie, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Novartis, Pfizer, Sanofi, and Shire. E. Zomer has received study grants from AstraZeneca, Pfizer, and Shire. This research funding is unrelated to this study, and the funding organization has no role in the design or interpretation of this study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asakura, E., Ademi, Z., Liew, D. et al. Productivity burden of hypertension in Japan. Hypertens Res 44, 1524–1533 (2021). https://doi.org/10.1038/s41440-021-00731-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-021-00731-0

Keywords

Search

Quick links